Srinivasan Yegnasubramanian
Affiliations: | Department of Oncology | Johns Hopkins University School of Medicine, Baltimore, MD, United States |
Google:
"Srinivasan Yegnasubramanian"Mean distance: (not calculated yet)
Children
Sign in to add traineeJonathan B Coulter | post-doc | Johns Hopkins Medical School | |
Mindy Kim Graham | post-doc | 2019- | Johns Hopkins Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Caramella-Pereira F, Zheng Q, Hicks JL, et al. (2025) Overexpression of fibroblast activation protein (FAP) in the stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate. Pathology |
Bai W, Xu J, Gu W, et al. (2025) Defining ortholog-specific UHRF1 inhibition by STELLA for cancer therapy. Nature Communications. 16: 474 |
Graham MK, Wang R, Chikarmane R, et al. (2024) Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer. Nature Communications. 15: 7414 |
Graham MK, Xu B, Davis C, et al. (2024) The TERT promoter is polycomb-repressed in neuroblastoma cells with long telomeres. Cancer Research Communications |
Caramella-Pereira F, Zheng Q, Hicks JL, et al. (2024) Overexpression of Fibroblast Activation Protein (FAP) in stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostate. Medrxiv : the Preprint Server For Health Sciences |
Markowski MC, Taplin ME, Aggarwal R, et al. (2024) Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. Nature Communications. 15: 14 |
Lee E, Coulter J, Mishra A, et al. (2023) Induction of double-strand breaks with the non-steroidal androgen receptor ligand flutamide in patients on androgen suppression: a study protocol for a randomized, double-blind prospective trial. Trials. 24: 809 |
Chen J, Zheng Q, Hicks JL, et al. (2023) MYC-driven increases in mitochondrial DNA copy number occur early and persist throughout prostatic cancer progression. Jci Insight |
Mori JO, Elhussin I, Brennen WN, et al. (2023) Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer. Nature Reviews. Urology |
Graham MK, Wang R, Chikarmane R, et al. (2023) Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer. Biorxiv : the Preprint Server For Biology |